NON-INVASIVE TOOLS FOR CVD SCREENING AND MONITORING
Dr Hadi Afsharan,
Research Fellow
University of Western Australia &
Harry Perkins Institute of Medical Research,
Perth, Western Australia
RESEARCHER PROFILE
Filmed in Perth, Australia | November 2025
Dr Hadi Afsharan is a Research Fellow Cardiovascular Science & Diabetes at the Harry Perkins Institute of Medical Research; is a translational research and innovation fellow in medical technologies at The University of Western Australia, holding dual titles as Translational Fellow and Innovation Fellow within UWA’s Medical School and the FHRI (Future Health Research and Innovation) program.
He earned his PhD in Biomedical Engineering from UWA in 2023, with a thesis entitled Development of Polarisation-Sensitive Optical Coherence Tomography for Application in Medical Diagnosis, which introduced a pioneering non-invasive imaging method for detecting hypertension and diabetes by analysing retinal blood vessel wall birefringence with exceptional sensitivity and specificity.
Hadi leads several translational research projects, including AI-based retinal biomarkers for coronary artery disease screening, low-cost imaging technologies for heart disease detection in remote communities, and radar-based non-contact measurement of jugular venous pressure, all supported by over $1.8 million in competitive funding from FHRI and UWA.
Source: Supplied
https://orcid.org/0000-0001-7874-2766
-
Vision impairment in children and the impact on children and their families
Dr Sue Silveira holds a conjoint academic position with Macquarie University and is the Course Director for their Master of Disability Studies, which is administered and delivered by NextSense Institute in affiliation with the University. She teaches in the areas of vision impairment and disability, and aims to share her knowledge while learning from others, especially people who are blind or have low vision and their families.
-
Exercise therapy for metabolic dysfunction-associated steatotic liver disease
Dr Shelley Keating is a Senior Lecturer in Clinical Exercise Physiology and Accredited Exercise Physiologist from the School of Human Movement and Nutrition Sciences at the University of Queensland. With a strong grounding in exercise metabolism and body composition, Dr Keating’s research centres on the utility of exercise as a therapy for obesity and related cardiometabolic conditions, notably metabolic dysfunction-associated steatotic liver disease (MASLD).
-
Genomics and rationally targeted therapies in Acute Lymphoblastic Leukaemia
Prof Deborah White’s research focus is genomics and rationally targeted therapies in Acute Lymphoblastic Leukaemia (ALL) and Chronic Myeloid Leukaemia (CML) and she holds peer reviewed grants from: The William Lawrence and Blanche Hughes Foundation and the Leukemia Lymphoma Society (USA), the NHMRC, the Leukaemia Foundation Australia (LFA), Channel 7, Cancer Australia, Tour de Cure and the Cancer Council SA (CCSA). Professor White has presented more than 170 papers at scientific meetings, and authored more than 100 scientific publications as well as being an inventor on several international patents.
